|
APOLD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.853800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.594200E-01 |
| Normal-vs-Stage2 |
4.458600E-01 |
| Normal-vs-Stage3 |
2.342000E-01 |
| Normal-vs-Stage4 |
3.784500E-02 |
| Stage1-vs-Stage2 |
2.865600E-01 |
| Stage1-vs-Stage3 |
1.683220E-01 |
| Stage1-vs-Stage4 |
1.254260E-02 |
| Stage2-vs-Stage3 |
5.587800E-02 |
| Stage2-vs-Stage4 |
1.027830E-02 |
| Stage3-vs-Stage4 |
3.078800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.588200E-01 |
| Normal-vs-AfricanAmerican |
3.009600E-01 |
| Normal-vs-Asian |
1.015740E-02 |
| Caucasian-vs-AfricanAmerican |
5.922300E-02 |
| Caucasian-vs-Asian |
9.244200E-03 |
| AfricanAmerican-vs-Asian |
1.512400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.107440E-01 |
| Normal-vs-Female |
8.818800E-01 |
| Male-vs-Female |
3.240400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.765800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.521400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.541600E-02 |
| Normal-vs-Age(81-100Yrs) |
2.629800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.527600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.199600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.236800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.181900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.404600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.434400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.06249999967767E-07 |
| Classical-VS-Follicular |
5.65390000000221E-05 |
| Classical-VS-Other |
3.713400E-01 |
| Classical-VS-Normal |
3.341000E-01 |
| Tall-VS-Follicular |
7.92432786056452E-12 |
| Tall-VS-Other |
2.850000E-01 |
| Tall-VS-Normal |
2.27090000000096E-05 |
| Follicular-VS-Other |
2.517500E-03 |
| Follicular-VS-Normal |
1.626090E-02 |
| Other-VS-Normal |
1.767180E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.773000E-01 |
| Normal-vs-N1 |
1.310150E-01 |
| N0-vs-N1 |
6.767600E-02 |
|
|
